Photoactivated DNA Nanodrugs Damage Mitochondria to Improve Gene Therapy for Reversing Chemoresistance

Danyu Wang,Hua Yi,Shizhen Geng,Chuanmei Jiang,Jingwen Liu,Jie Duan,Zhenzhong Zhang,Jinjin Shi,Haiwei Song,Zhenzhen Guo,Kaixiang Zhang
DOI: https://doi.org/10.1021/acsnano.3c04002
IF: 17.1
2023-08-23
ACS Nano
Abstract:Multidrug resistance (MDR) is a major cause of chemotherapy failure in oncology, and gene therapy is an excellent measure to reverse MDR. However, conventional gene therapy only modulates the expression of MDR-associated proteins but hardly affects their existing function, thus limiting the efficiency of tumor treatment. Herein, we designed a photoactivated DNA nanodrug (MCD@TMPyP(4)@DOX) to improve tumor chemosensitivity through the downregulation of MDR-related genes and mitochondria-targeted...
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
What problem does this paper attempt to address?
This paper aims to address the issue of multidrug resistance (MDR) in tumor cells, particularly the limitation of drug efficacy during chemotherapy. Specifically, the paper proposes a photo-activated DNA nanomedicine (MCD@TMPyP4@DOX) that targets the mitochondria within tumor cells and combines gene regulation strategies to enhance chemotherapy sensitivity. This method not only downregulates the expression of genes associated with MDR but also damages mitochondria through photodynamic therapy (PDT), thereby reducing ATP production, inhibiting the function of P-glycoprotein (P-gp), and ultimately improving the efficacy of chemotherapeutic drugs.